| Product NDC: | 25010-305 | 
| Proprietary Name: | Demser | 
| Non Proprietary Name: | metyrosine | 
| Active Ingredient(s): | 250 mg/1 & nbsp; metyrosine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25010-305 | 
| Labeler Name: | Aton Pharma, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA017871 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19791003 | 
| Package NDC: | 25010-305-15 | 
| Package Description: | 100 CAPSULE in 1 BOTTLE (25010-305-15) | 
| NDC Code | 25010-305-15 | 
| Proprietary Name | Demser | 
| Package Description | 100 CAPSULE in 1 BOTTLE (25010-305-15) | 
| Product NDC | 25010-305 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | metyrosine | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19791003 | 
| Marketing Category Name | NDA | 
| Labeler Name | Aton Pharma, Inc. | 
| Substance Name | METYROSINE | 
| Strength Number | 250 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Catecholamine Synthesis Inhibitor [EPC],Catecholamine Synthesis Inhibitors [MoA] |